News & Insights
Data Deals Briefing
Daily, sourced analysis of the global market for data — acquisitions, AI-data partnerships, funding and regulation.
Data Academy
New to buying or selling data? Start with our practical guides.
Pfizer–Innovent Strike a $10B Cancer-Data Licensing Pact
Pfizer and Innovent's licensing deal—worth up to $10 billion—headlined a busy week that underscored the soaring value of proprietary data and IP. Snowflake's acquisition of Natoma and new US privacy legislation signal a data market maturing fast around AI governance.
Read the briefing →Snowflake Commits $6B to AWS to Power Enterprise Agentic AI
Snowflake's $6 billion, multi-year commitment to AWS headlined a wave of AI-infrastructure deals, from SoftBank's 1 GW data-center campus in France to Advaya's acquisition of Comscore Movies. With AI startups capturing 81% of Q1 2026 venture funding, demand for licensed data and compute is compounding fast.
Read the briefing →Anthropic Raises $65B at a $965B Valuation
Anthropic's $65 billion Series H—valuing the lab at $965 billion—headlined a record stretch of AI funding and data M&A. From CoStar's $800 million purchase of housing-data firm Zonda to tighter GDPR enforcement, the premium on proprietary data keeps rising.
Read the briefing →